annual EBITDA:
$1.69B+$573.00M(+51.16%)Summary
- As of today (May 29, 2025), XYL annual EBITDA is $1.69 billion, with the most recent change of +$573.00 million (+51.16%) on December 31, 2024.
- During the last 3 years, XYL annual EBITDA has risen by +$861.00 million (+103.49%).
- XYL annual EBITDA is now at all-time high.
Performance
XYL EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$370.00M-$156.00M(-29.66%)Summary
- As of today (May 29, 2025), XYL quarterly EBITDA is $370.00 million, with the most recent change of -$156.00 million (-29.66%) on March 31, 2025.
- Over the past year, XYL quarterly EBITDA has increased by +$26.00 million (+7.56%).
- XYL quarterly EBITDA is now -29.66% below its all-time high of $526.00 million, reached on December 31, 2024.
Performance
XYL quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$1.72B+$26.00M(+1.54%)Summary
- As of today (May 29, 2025), XYL TTM EBITDA is $1.72 billion, with the most recent change of +$26.00 million (+1.54%) on March 31, 2025.
- Over the past year, XYL TTM EBITDA has increased by +$450.00 million (+35.46%).
- XYL TTM EBITDA is now at all-time high.
Performance
XYL TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
XYL EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +51.2% | +7.6% | +35.5% |
| 3 y3 years | +103.5% | +118.9% | +113.8% |
| 5 y5 years | +128.8% | +203.3% | +150.6% |
XYL EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +133.2% | -29.7% | +325.3% | at high | +159.7% |
| 5 y | 5-year | at high | +176.2% | -29.7% | +325.3% | at high | +204.8% |
| alltime | all time | at high | +349.1% | -29.7% | +436.2% | at high | +1768.5% |
XYL EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $370.00M(-29.7%) | $1.72B(+1.5%) |
| Dec 2024 | $1.69B(+51.2%) | $526.00M(+25.2%) | $1.69B(+10.8%) |
| Sep 2024 | - | $420.00M(+4.2%) | $1.53B(+5.1%) |
| Jun 2024 | - | $403.00M(+17.2%) | $1.45B(+14.6%) |
| Mar 2024 | - | $344.00M(-4.7%) | $1.27B(+13.3%) |
| Dec 2023 | $1.12B(+54.3%) | $361.00M(+4.3%) | $1.12B(+9.7%) |
| Sep 2023 | - | $346.00M(+58.7%) | $1.02B(+34.0%) |
| Jun 2023 | - | $218.00M(+11.8%) | $762.00M(+1.3%) |
| Mar 2023 | - | $195.00M(-25.6%) | $752.00M(+3.6%) |
| Dec 2022 | $726.00M(-12.7%) | $262.00M(+201.1%) | $726.00M(+9.7%) |
| Sep 2022 | - | $87.00M(-58.2%) | $662.00M(-16.3%) |
| Jun 2022 | - | $208.00M(+23.1%) | $791.00M(-1.6%) |
| Mar 2022 | - | $169.00M(-14.6%) | $804.00M(-3.4%) |
| Dec 2021 | $832.00M(+35.7%) | $198.00M(-8.3%) | $832.00M(-4.9%) |
| Sep 2021 | - | $216.00M(-2.3%) | $875.00M(+10.2%) |
| Jun 2021 | - | $221.00M(+12.2%) | $794.00M(+15.4%) |
| Mar 2021 | - | $197.00M(-18.3%) | $688.00M(+12.2%) |
| Dec 2020 | $613.00M(-17.2%) | $241.00M(+78.5%) | $613.00M(-2.7%) |
| Sep 2020 | - | $135.00M(+17.4%) | $630.00M(+11.7%) |
| Jun 2020 | - | $115.00M(-5.7%) | $564.00M(-17.8%) |
| Mar 2020 | - | $122.00M(-52.7%) | $686.00M(-7.3%) |
| Dec 2019 | $740.00M(-20.3%) | $258.00M(+273.9%) | $740.00M(-0.8%) |
| Sep 2019 | - | $69.00M(-70.9%) | $746.00M(-19.1%) |
| Jun 2019 | - | $237.00M(+34.7%) | $922.00M(+0.1%) |
| Mar 2019 | - | $176.00M(-33.3%) | $921.00M(-0.8%) |
| Dec 2018 | $928.00M(+18.7%) | $264.00M(+7.8%) | $928.00M(+4.5%) |
| Sep 2018 | - | $245.00M(+3.8%) | $888.00M(+4.1%) |
| Jun 2018 | - | $236.00M(+29.0%) | $853.00M(+4.5%) |
| Mar 2018 | - | $183.00M(-18.3%) | $816.00M(+4.3%) |
| Dec 2017 | $782.00M | $224.00M(+6.7%) | $782.00M(+8.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2017 | - | $210.00M(+5.5%) | $722.00M(+10.2%) |
| Jun 2017 | - | $199.00M(+33.6%) | $655.00M(+9.3%) |
| Mar 2017 | - | $149.00M(-9.1%) | $599.00M(+6.8%) |
| Dec 2016 | $561.00M(-5.1%) | $164.00M(+14.7%) | $561.00M(-1.6%) |
| Sep 2016 | - | $143.00M(0.0%) | $570.00M(-1.7%) |
| Jun 2016 | - | $143.00M(+28.8%) | $580.00M(+0.7%) |
| Mar 2016 | - | $111.00M(-35.8%) | $576.00M(-2.5%) |
| Dec 2015 | $591.00M(-4.2%) | $173.00M(+13.1%) | $591.00M(-0.5%) |
| Sep 2015 | - | $153.00M(+10.1%) | $594.00M(-3.9%) |
| Jun 2015 | - | $139.00M(+10.3%) | $618.00M(-2.2%) |
| Mar 2015 | - | $126.00M(-28.4%) | $632.00M(+2.4%) |
| Dec 2014 | $617.00M(+22.7%) | $176.00M(-0.6%) | $617.00M(+2.5%) |
| Sep 2014 | - | $177.00M(+15.7%) | $602.00M(+7.9%) |
| Jun 2014 | - | $153.00M(+37.8%) | $558.00M(+8.8%) |
| Mar 2014 | - | $111.00M(-31.1%) | $513.00M(+2.0%) |
| Dec 2013 | $503.00M(-14.0%) | $161.00M(+21.1%) | $503.00M(+3.9%) |
| Sep 2013 | - | $133.00M(+23.1%) | $484.00M(-3.4%) |
| Jun 2013 | - | $108.00M(+6.9%) | $501.00M(-9.6%) |
| Mar 2013 | - | $101.00M(-28.9%) | $554.00M(-5.3%) |
| Dec 2012 | $585.00M(+8.9%) | $142.00M(-5.3%) | $585.00M(+1.7%) |
| Sep 2012 | - | $150.00M(-6.8%) | $575.00M(+5.7%) |
| Jun 2012 | - | $161.00M(+22.0%) | $544.00M(+1.9%) |
| Mar 2012 | - | $132.00M(0.0%) | $534.00M(-0.4%) |
| Dec 2011 | $537.00M(+11.9%) | $132.00M(+10.9%) | $536.00M(-0.7%) |
| Sep 2011 | - | $119.00M(-21.2%) | $540.00M(+1.7%) |
| Jun 2011 | - | $151.00M(+12.7%) | $531.00M(+39.7%) |
| Mar 2011 | - | $134.00M(-1.5%) | $380.00M(+12.4%) |
| Dec 2010 | $480.00M(+27.3%) | $136.00M(+23.6%) | $338.00M(+67.3%) |
| Sep 2010 | - | $110.00M(+19.6%) | $202.00M(+119.6%) |
| Mar 2010 | - | $92.00M | $92.00M |
| Dec 2009 | $377.00M | - | - |
FAQ
- What is Xylem annual EBITDA?
- What is the all time high annual EBITDA for Xylem?
- What is Xylem annual EBITDA year-on-year change?
- What is Xylem quarterly EBITDA?
- What is the all time high quarterly EBITDA for Xylem?
- What is Xylem quarterly EBITDA year-on-year change?
- What is Xylem TTM EBITDA?
- What is the all time high TTM EBITDA for Xylem?
- What is Xylem TTM EBITDA year-on-year change?
What is Xylem annual EBITDA?
The current annual EBITDA of XYL is $1.69B
What is the all time high annual EBITDA for Xylem?
Xylem all-time high annual EBITDA is $1.69B
What is Xylem annual EBITDA year-on-year change?
Over the past year, XYL annual EBITDA has changed by +$573.00M (+51.16%)
What is Xylem quarterly EBITDA?
The current quarterly EBITDA of XYL is $370.00M
What is the all time high quarterly EBITDA for Xylem?
Xylem all-time high quarterly EBITDA is $526.00M
What is Xylem quarterly EBITDA year-on-year change?
Over the past year, XYL quarterly EBITDA has changed by +$26.00M (+7.56%)
What is Xylem TTM EBITDA?
The current TTM EBITDA of XYL is $1.72B
What is the all time high TTM EBITDA for Xylem?
Xylem all-time high TTM EBITDA is $1.72B
What is Xylem TTM EBITDA year-on-year change?
Over the past year, XYL TTM EBITDA has changed by +$450.00M (+35.46%)